Cornea/External Disease News

Tarsus Pharmaceuticals has launched a campaign for Xdemvy to raise consumer awareness about Demodex blepharitis, according to a press release.

Brassica Pharma has initiated a voluntary recall of its eye ointment products after an FDA inspection of a Brassica facility found a “lack of sterility assurance.”

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Farhad Hafezi, MD, PhD, speaks about cross-linking in the treatment of infectious keratitis.

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.

ATLANTA —There is limited evidence to show that LipiFlow is more effective than commonly used treatments for dry eye disease and meibomian gland dysfunction, according to recently published research.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Lamis Baydoun, MD, PhD, encourages colleagues to use phakic DMEK and gives pearls for safe, efficient and successful surgery.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Fabrizio Camesasca, MD, speaks about sequential customized phototherapeutic keratectomy.

ATLANTA — Stem cell deficiencies are considered noninfectious sight-threatening complications, so early diagnosis is critical, according to Joseph P. Shovlin, OD, FAAO.

Local firework bans may be linked with a slight reduction in the odds of firework-related ocular trauma, according to research published in JAMA Ophthalmology.

The No. 1 thing I hear from patients — whether they are first-time or established contact lens wearers — is that they want lenses they can comfortably wear all day.